Ding-Wei Ye (Dingwei Ye)

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 14

Top Venues

Phenomics (Cham, Switzerland)

World journal of surgical oncology

Cancer biology & medicine

Cancer immunology, immunotherapy : CII

This page only lists publications with an associated author ORCID identifier.

Publications

Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li, Ding-Wei Ye
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer. Cancer biology & medicine 20 (12) (2024)
Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li, Ding-Wei Ye
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer. Cancer biology & medicine 20 (12) (2024)
Nanhui Chen, Zengjun Wang, Ming Chen, Qi Ma, Yi He, Yujie Wang, Xin Li, Mingxing Qiu, Lei Shi, Shaoxing Zhu, Qun Xie, Xiuheng Liu, Benkang Shi, Guowen Lin, Weizhong Yang, Yongbin Liao, Haibin Zhang, Shusheng Wang, Jiexian Li, Shaogang Wang, Lijun Dong, Hui Chen, Jiaju Lu, Yongyi Cheng, Xiaoping Zhang, Lulin Ma, Liqun Zhou, He Wang, Shen Li, Ding-Wei Ye
Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer. Cancer biology & medicine 20 (12) (2024)
Wenhao Xu, Wangrui Liu, Jianfeng Yang, Jiahe Lu, Hailiang Zhang, Ding-Wei Ye
Stimuli-responsive nanodelivery systems for amplifying immunogenic cell death in cancer immunotherapy. Immunological reviews (2023)
Yue Wang, Xi Tian, Shu-Xuan Zhu, Wen-Hao Xu, Aihetaimujiang Anwaier, Jia-Qi Su, Hua-Lei Gan, Yuan-Yuan Qu, Jian-Yuan Zhao, Hai-Liang Zhang, Ding-Wei Ye
Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. World journal of surgical oncology 21 (1) (2023)
Yue Wang, Xi Tian, Shu-Xuan Zhu, Wen-Hao Xu, Aihetaimujiang Anwaier, Jia-Qi Su, Hua-Lei Gan, Yuan-Yuan Qu, Jian-Yuan Zhao, Hai-Liang Zhang, Ding-Wei Ye
Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. World journal of surgical oncology 21 (1) (2023)
Yue Wang, Xi Tian, Shu-Xuan Zhu, Wen-Hao Xu, Aihetaimujiang Anwaier, Jia-Qi Su, Hua-Lei Gan, Yuan-Yuan Qu, Jian-Yuan Zhao, Hai-Liang Zhang, Ding-Wei Ye
Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma. World journal of surgical oncology 21 (1) (2023)
Xi Tian, Yue Wang, Wen-Hao Xu, Haidan Tang, Shuxuan Zhu, Aihetaimujiang Anwaier, Wang-Rui Liu, Wenfeng Wang, Wenkai Zhu, Jiaqi Su, Yuanyuan Qu, Hailiang Zhang, Ding-Wei Ye
Special issue "The advance of solid tumor research in China": Multi-omics analysis based on 1311 clear cell renal cell carcinoma samples identifies a glycolysis signature associated with prognosis and treatment response. International journal of cancer 152 (1) (2022)
Aihetaimujiang Anwaier, Shu-Xuan Zhu, Xi Tian, Wen-Hao Xu, Yue Wang, Maierdan Palihati, Wei-Yue Wang, Guo-Hai Shi, Yuan-Yuan Qu, Hai-Liang Zhang, Ding-Wei Ye
Large-Scale Proteomics Data Reveal Integrated Prognosis-Related Protein Signatures and Role of SMAD4 and RAD50 in Prognosis and Immune Infiltrations of Prostate Cancer Microenvironment. Phenomics (Cham, Switzerland) 2 (6) (2022)
Wenhao Xu, Chunguang Ma, Wangrui Liu, Aihetaimujiang Anwaier, Xi Tian, Guohai Shi, Yuanyuan Qu, Shiyin Wei, Hailiang Zhang, Ding-Wei Ye
Prognostic value, DNA variation and immunologic features of a tertiary lymphoid structure-related chemokine signature in clear cell renal cell carcinoma. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Aihetaimujiang Anwaier, Shu-Xuan Zhu, Xi Tian, Wen-Hao Xu, Yue Wang, Maierdan Palihati, Wei-Yue Wang, Guo-Hai Shi, Yuan-Yuan Qu, Hai-Liang Zhang, Ding-Wei Ye
Large-Scale Proteomics Data Reveal Integrated Prognosis-Related Protein Signatures and Role of SMAD4 and RAD50 in Prognosis and Immune Infiltrations of Prostate Cancer Microenvironment. Phenomics (Cham, Switzerland) 2 (6) (2022)
Wen-Jie Luo, Jun Wang, Wenhao Xu, Chunguang Ma, Fangning Wan, Yongqiang Huang, Mengfei Yao, Hailiang Zhang, Yuanyuan Qu, Ding-Wei Ye, Yi-Ping Zhu
LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer. Cell death & disease 12 (11) (2021)
Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu, Xi Tian, Wen-Kai Zhu, Jian Wang, Yuanyuan Qu, Hailiang Zhang, Ding-Wei Ye
Systematic Genome-Wide Profiles Reveal Alternative Splicing Landscape and Implications of Splicing Regulator DExD-Box Helicase 21 in Aggressive Progression of Adrenocortical Carcinoma. Phenomics (Cham, Switzerland) 1 (6) (2021)
Wenhao Xu, Aihetaimujiang Anwaier, Wangrui Liu, Xi Tian, Wen-Kai Zhu, Jian Wang, Yuanyuan Qu, Hailiang Zhang, Ding-Wei Ye
Systematic Genome-Wide Profiles Reveal Alternative Splicing Landscape and Implications of Splicing Regulator DExD-Box Helicase 21 in Aggressive Progression of Adrenocortical Carcinoma. Phenomics (Cham, Switzerland) 1 (6) (2021)

Ding-Wei Ye.css-eqlu8i{font-size:small;padding-left:4px;} (Dingwei Ye)

Publication Activity (10 Years)

Top Topics

Top Venues

Ding-Wei Ye (Dingwei Ye)